Pilot study to investigate whether oral phosphorus binders can reduce FGF23 levels and can influence vascular function as measured by pulse wave velocity in patiens with chronic kidney disease stage 3 (eGFR 30-60 ml/min/1,73 m2).

Category Primary study
Registry of TrialsOverview of Medical Research in the Netherlands
Year 2010
This article has no abstract
Epistemonikos ID: cd4bc714bd1a72f178e271fce9f8b33f1ccf1a3d
First added on: Apr 16, 2025